中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

22 records (took 0.027 seconds)

    Methods and compositions for labeling nucleic acids
    12.
    发明授权
    Methods and compositions for labeling nucleic acids 有权

    公开(公告)号：US09512465B2

    公开(公告)日：2016-12-06

    申请号：US13972365

    申请日：2013-08-21

    Applicant: President and Fellows of Harvard College ,  Life Technologies Corporation

    Inventor： Kyle R. Gee ,  Brian Agnew ,  Adrian Salic ,  Timothy J. Mitchison

    IPC: C12Q1/68 ,  G01N33/50 ,  G01N33/58

    CPC classification number: C12Q1/6806 ,  C12Q1/68 ,  C12Q1/6816 ,  C12Q1/6841 ,  G01N33/5011 ,  G01N33/582 ,  C12Q2525/101 ,  C12Q2563/107

    Abstract: The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. Certain methods are provided that include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label. Other methods are provided that include a Staudinger ligation between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent comprising a substituted triarylphosphine attached to a label. Such methods do not require fixation and denaturation and therefore can be applied to the labeling of nucleic acid polymers in living cells and in organisms. Also provided are methods for measuring cellular proliferation. In these methods, the amount of label incorporated into the DNA is measured as an indication of cellular proliferation. The methods of the invention can be used in a wide variety of applications including clinical diagnosis of diseases and disorders in which cellular proliferation is involved, toxicity assays, and as a tool for the study of chromosomes' ultrastructures.

    METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS
    15.
    发明申请
    METHODS AND COMPOSITIONS FOR LABELING NUCLEIC ACIDS 有权
    标记核酸的方法和组合物

    公开(公告)号：US20140065605A1

    公开(公告)日：2014-03-06

    申请号：US13972365

    申请日：2013-08-21

    Applicant: Life Technologies Corporation ,  President and Fellows of Harvard College

    Inventor： Kyle R. Gee ,  Brian Agnew ,  Adrian Salic ,  Timothy J. Mitchison

    IPC: C12Q1/68

    CPC classification number: C12Q1/6806 ,  C12Q1/68 ,  C12Q1/6816 ,  C12Q1/6841 ,  G01N33/5011 ,  G01N33/582 ,  C12Q2525/101 ,  C12Q2563/107

    Abstract: The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. Certain methods are provided that include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label. Other methods are provided that include a Staudinger ligation between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent comprising a substituted triarylphosphine attached to a label. Such methods do not require fixation and denaturation and therefore can be applied to the labeling of nucleic acid polymers in living cells and in organisms. Also provided are methods for measuring cellular proliferation. In these methods, the amount of label incorporated into the DNA is measured as an indication of cellular proliferation. The methods of the invention can be used in a wide variety of applications including clinical diagnosis of diseases and disorders in which cellular proliferation is involved, toxicity assays, and as a tool for the study of chromosomes' ultrastructures.

    Abstract translation: 本发明涉及体外和体内标记核酸聚合物的方法。 提供了包括掺入核酸聚合物的核苷酸类似物与附着于标记物上的试剂之间的[3 + 2]环加成的某些方法。 提供了包括掺入核酸聚合物的核苷酸类似物与包含连接到标签上的取代的三芳基膦的试剂之间的施陶丁格连接的其它方法。 这种方法不需要固定和变性，因此可以应用于活细胞和生物体中核酸聚合物的标记。 还提供了测量细胞增殖的方法。 在这些方法中，测量结合到DNA中的标记量作为细胞增殖的指示。 本发明的方法可用于各种应用，包括涉及细胞增殖的疾病和病症的临床诊断，毒性测定以及用于研究染色体超微结构的工具。

    Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
    18.
    发明授权
    Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids 有权

    公开(公告)号：US10808228B2

    公开(公告)日：2020-10-20

    申请号：US15865713

    申请日：2018-01-09

    Applicant: Life Technologies Corporation ,  The Johns Hopkins University

    Inventor： Brian Agnew ,  David Graham

    IPC: C12N7/00 ,  A61K39/00 ,  A61K48/00

    Abstract: Methods of using viruses labeled with alkyne-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to increase the infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an alkyne-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The viruses labeled with alkyne-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.

    Anti-Viral Azide Containing Compounds
    19.
    发明申请
    Anti-Viral Azide Containing Compounds 审中-公开

    公开(公告)号：US20190105334A1

    公开(公告)日：2019-04-11

    申请号：US16208251

    申请日：2018-12-03

    Applicant: Life Technologies Corporation

    Inventor： Brian Agnew ,  Upinder Singh ,  Scott Grecian

    IPC: A61K31/655 ,  A61K31/7008 ,  C12N7/00

    Abstract: Methods of using azide-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to inhibit infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. Also, provided are methods of tracking a virus in vivo, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The azide-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.

    Anti-viral azide containing compounds
    20.
    发明授权
    Anti-viral azide containing compounds 有权

    公开(公告)号：US10179143B2

    公开(公告)日：2019-01-15

    申请号：US15671360

    申请日：2017-08-08

    Applicant: LIFE TECHNOLOGIES CORPORATION

    Inventor： Brian Agnew ,  Upinder Singh ,  Scott Grecian

    IPC: A61K31/655 ,  A61K31/7024 ,  A61K45/06 ,  A61K49/00 ,  A61K31/7088 ,  C12N7/00 ,  A61K31/7008

    Abstract: Methods of using azide-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to inhibit infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. Also, provided are methods of tracking a virus in vivo, with an azide-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The azide-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.

Patent Agency Ranking